Jim Cramer Discussed 10 Stocks Leading the Dow Higher in 2025

5. Amgen Inc. (NASDAQ:AMGN)

Number of Hedge Fund Holders: 68

Taking the fifth spot on the list of stocks that have led the Dow higher in 2025, Amgen Inc. (NASDAQ:AMGN) was discussed during the episode and Cramer stated:

“Fifth is Amgen. And this, this one has so many blockbuster drugs. I think it’s absurd that the stock, once again sells for really 14 times earnings. The flagship drug is Repatha, which is the best medicine to lower cholesterol. They have studies showing that any amount of cholesterol is bad so the sales just keep going higher and higher. Why isn’t Amgen better known? I think it’s because people don’t know about its amazing anti-cancer franchise.

When the company brings its weight loss drug MariTide to market, I bet that people will finally sit up and take notice. In fact, many clued in people have already spotted it hence the recent gains. MariTide looks like it help[s] you lose weight as much as the majors. But unlike Ozempic or Mounjaro, it only requires once a month injection instead of once a week. Nobody wants more injections when they can have fewer.”

Amgen (NASDAQ:AMGN) develops and delivers a variety of human therapeutics, including treatments for conditions such as psoriasis, arthritis, osteoporosis, cardiovascular diseases, and cancer.